Kübler K - Search Results

1

Immune Profiling of Vulvar Squamous Cell Cancer Discovers a Macrophage-rich Subtype Associated with Poor Prognosis.

Condic M, Rohr A, Riemann S, Staerk C, Ayub TH, Doeser A, Zillinger T, Merkelbach-Bruse S, Buettner R, Barchet W, Rudlowski C, Mustea A, Kübler K. Condic M, et al. Among authors: kubler k. Cancer Res Commun. 2024 Mar 21;4(3):861-875. doi: 10.1158/2767-9764.CRC-22-0366. Cancer Res Commun. 2024. PMID: 38407373 Free PMC article.

2

Targeted activation of RNA helicase retinoic acid-inducible gene-I induces proimmunogenic apoptosis of human ovarian cancer cells.

Kübler K, Gehrke N, Riemann S, Böhnert V, Zillinger T, Hartmann E, Pölcher M, Rudlowski C, Kuhn W, Hartmann G, Barchet W. Kübler K, et al. Cancer Res. 2010 Jul 1;70(13):5293-304. doi: 10.1158/0008-5472.CAN-10-0825. Epub 2010 Jun 15. Cancer Res. 2010. PMID: 20551064

3

N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.

Condic M, Thiesler T, Staerk C, Klümper N, Ellinger J, Egger EK, Kübler K, Kristiansen G, Mustea A, Ralser DJ. Condic M, et al. Among authors: kubler k. BMC Cancer. 2022 Sep 1;22(1):943. doi: 10.1186/s12885-022-10010-x. BMC Cancer. 2022. PMID: 36050747 Free PMC article.

4

Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology.

Hecking T, Thiesler T, Schiller C, Lunkenheimer JM, Ayub TH, Rohr A, Condic M, Keyver-Paik MD, Fimmers R, Kirfel J, Kuhn W, Kristiansen G, Kübler K. Hecking T, et al. Among authors: kubler k. Oncotarget. 2017 Oct 6;8(54):92890-92903. doi: 10.18632/oncotarget.21641. eCollection 2017 Nov 3. Oncotarget. 2017. PMID: 29190964 Free PMC article.

5

Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells.

Kübler K, tho Pesch C, Gehrke N, Riemann S, Dassler J, Coch C, Landsberg J, Wimmenauer V, Pölcher M, Rudlowski C, Tüting T, Kuhn W, Hartmann G, Barchet W. Kübler K, et al. Eur J Immunol. 2011 Oct;41(10):3028-39. doi: 10.1002/eji.201141555. Epub 2011 Aug 30. Eur J Immunol. 2011. PMID: 21728171 Free article.

6

Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma.

Kübler K, Ayub TH, Weber SK, Zivanovic O, Abramian A, Keyver-Paik MD, Mallmann MR, Kaiser C, Serçe NB, Kuhn W, Rudlowski C. Kübler K, et al. Gynecol Oncol. 2014 Nov;135(2):176-83. doi: 10.1016/j.ygyno.2014.08.028. Epub 2014 Aug 27. Gynecol Oncol. 2014. PMID: 25173585

7

c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia.

Kübler K, Heinenberg S, Rudlowski C, Keyver-Paik MD, Abramian A, Merkelbach-Bruse S, Büttner R, Kuhn W, Schildhaus HU. Kübler K, et al. Oncotarget. 2015 Jan 20;6(2):825-35. doi: 10.18632/oncotarget.2706. Oncotarget. 2015. PMID: 25596731 Free PMC article.

8

Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.

Ayub TH, Keyver-Paik MD, Debald M, Rostamzadeh B, Thiesler T, Schröder L, Barchet W, Abramian A, Kaiser C, Kristiansen G, Kuhn W, Kübler K. Ayub TH, et al. Among authors: kubler k. Oncotarget. 2015 Jun 30;6(18):16437-48. doi: 10.18632/oncotarget.4103. Oncotarget. 2015. PMID: 25999351 Free PMC article.

9

Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer.

Pölcher M, Eckhardt M, Coch C, Wolfgarten M, Kübler K, Hartmann G, Kuhn W, Rudlowski C. Pölcher M, et al. Among authors: kubler k. Cancer Chemother Pharmacol. 2010 May;66(1):203-7. doi: 10.1007/s00280-010-1276-2. Epub 2010 Mar 5. Cancer Chemother Pharmacol. 2010. PMID: 20204367 Free article. Clinical Trial.

10

In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer.

Pölcher M, Rudlowski C, Friedrichs N, Mielich M, Höller T, Wolfgarten M, Kübler K, Büttner R, Kuhn W, Braun M. Pölcher M, et al. Among authors: kubler k. BMC Cancer. 2010 Apr 13;10:137. doi: 10.1186/1471-2407-10-137. BMC Cancer. 2010. PMID: 20388201 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters